UnitedHealth Group (NYSE:UNH) will issue its quarterly earnings data before the market opens on Tuesday, October 16th. Analysts expect the company to announce earnings of $3.30 per share for the quarter. UnitedHealth Group has set its FY18 guidance at $12.50-12.75 EPS.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the consensus estimate of $3.04 by $0.10. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The company had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. During the same quarter in the previous year, the business posted $2.46 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.1% on a year-over-year basis. On average, analysts expect UnitedHealth Group to post $13 EPS for the current fiscal year and $14 EPS for the next fiscal year.
Shares of UNH opened at $259.61 on Friday. UnitedHealth Group has a fifty-two week low of $186.00 and a fifty-two week high of $272.07. The firm has a market capitalization of $256.06 billion, a P/E ratio of 25.78, a price-to-earnings-growth ratio of 1.58 and a beta of 0.73. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.63.
UNH has been the topic of several research reports. Citigroup cut shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price target on the stock. in a research report on Monday, September 10th. Raymond James boosted their price target on shares of UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. Finally, ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. One equities research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $279.26.
In other news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $254.79, for a total transaction of $3,821,850.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the sale, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at $17,549,384.58. The disclosure for this sale can be found here. Insiders have sold 94,745 shares of company stock worth $24,995,290 in the last quarter. Company insiders own 0.87% of the company’s stock.
An institutional investor recently raised its position in UnitedHealth Group stock. Argent Trust Co grew its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,911 shares of the healthcare conglomerate’s stock after purchasing an additional 1,061 shares during the quarter. UnitedHealth Group makes up approximately 0.8% of Argent Trust Co’s investment portfolio, making the stock its 15th largest position. Argent Trust Co’s holdings in UnitedHealth Group were worth $3,066,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 85.35% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What does the Dow Jones Industrial Average (DJIA) measure?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.